Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAngle Share News (AGL)

Share Price Information for Angle (AGL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 19.25
Bid: 19.00
Ask: 19.50
Change: 0.50 (2.67%)
Spread: 0.50 (2.632%)
Open: 18.75
High: 19.25
Low: 18.75
Prev. Close: 18.75
AGL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK WINNERS & LOSERS: Hunting Slides After Warning On Low Oil Price

Mon, 16th Feb 2015 11:27

LONDON (Alliance News) - The following stocks are amongst the biggest risers and fallers within the main London indices midday Monday.
-------
FTSE 100 WINNERS
-------
SABMiller, up 1.9%. A group of South American billionaires is understood to be considering making a GBP75 billion bid for the brewer, the Daily Mail's This is Money reported on Saturday. 3G Capital, a secretive investment firm run by a group of Brazilian investors, is also believed to have been studying whether it could be part of a consortium to bid for SABMiller which could include Anheuser-Busch InBev, the maker of Budweiser and Stella Artois, the Mail said, citing City sources. However, a note issued by Nomura says simply: "We are sceptical."
-------
FTSE 100 LOSERS
-------
AstraZeneca, down 1.4%. The pharmaceutical company said a US court has ruled its patent on its Pulmicort Repsules asthma treatment invalid, but said the decision will not impact its guidance for 2015. The group said the decision does not impact on the validity of its patents for the product in other countries.

Rolls-Royce Holdings, down 0.7%. The aerospace group has become embroiled in the multibillion-dollar bribery and kickback scandal involving Brazilian state-controlled oil company Petrobras, the Financial Times reported on Sunday. Rolls-Royce, which makes gas turbines used in Petrobras's oil platforms, is alleged to have paid bribes via an agent in exchange for a USD100 million contract under a scheme believed to have been in operation for much of the past decade, the FT said, citing statements made by a former Petrobras executive.
-------
FTSE 250 WINNERS
-------
Jimmy Choo, up 5.5%. HSBC has raised the luxury shoemaker's rating to Overweight from Neutral, and its price target to 205 pence from 190p.

Melrose Industries, up 2.4%. Goldman has lifted its recommendation for the company to Conviction Buy from Neutral.
-------
FTSE 250 LOSERS
-------
Hunting, down 8.8%. The energy services group said it is possible that some its businesses will report growth in the year ahead, while others will be affected by the wider sector downturn. The energy services group said the early part of 2015 has seen the global energy industry reset its expenditure and profitability expectations in light of the anticipation of sustained lower prices for oil and gas. Expenditure estimates for the company's customers for the current year continue to evolve rapidly in light of changing oil prices, it said. "Hunting does not believe that it is appropriate at this stage to provide financial guidance for 2015," it said.

Fidessa Group, down 2.6%. The financial trading systems company reported a fall in profit for 2014, exacerbated by the strength of sterling, its reporting currency, but upped its annual dividend by 3% to 38.1 pence per share and kept its special dividend flat at 45.0 pence, while the group also said it expects a gradual increase in its growth rate in 2015.
-------
AIM ALL-SHARE WINNERS
-------
Red Emperor Resources, up 43%. The group said it is in advanced talks with a number of projects as more opportunities become available due to the fall in the price of oil. In a statement, Red Emperor said its current cash position is in excess of AUD10 million, following the sale of its direct equity investment in Highfield Resources Ltd.

Tri-Star Resources, up 27%. The company said Oman-based Strategic & Precious Metals Processing has signed a financing deal with local lender Bank Nizwa. Tri-Star owns a 40% stake in Strategic & Precious Metals Processing. The financing deal comprises a USD40 million Shariah-compliant facility which will back the Oman antimony roaster project which Strategic & Precious Metals Processing is heading.

Bahamas Petroleum Co, up 18%. The oil company said analysis on three historical wells in the Bahamas demonstrates the presence of an active petroleum system within the site and said its first exploration well has been re-engineered, cutting exploration costs substantially.

JQW, up 17%. The group said its revenue for 2014 will be ahead of market expectations. JQW said revenue for the year to the end of December was around CNY784 million, up from the CNY490 million reported a year earlier. Pretax profit for the year is expected to be around CNY212 million, up from CNY170 million last year.

Plant Impact, up 10%. The company, which makes speciality nutrition products for crops, said it has signed a further agreement with Bayer CropScience to develop yield enhancing technologies for soy cultivation. Under the deal, Bayer CropScience will make payments to Plant Impact of up to USD9 million, comprising an initial USD3 million payment and up to USD6 million based on a range of milestones being achieved.
-------
AIM ALL-SHARE LOSERS
-------
ANGLE, off 12% at 74.00p. The company's shares are down after it launched a discounted share placing to raise GBP7.3 million, along with a further share offer to raise another GBP1.5 million. ANGLE said it has raised GBP7.3 million via the placing of 10.3 million shares and a subscription for a further 901,000, both at 65 pence per share.

Mwana Africa, down 9.1%. The company reported drops in gold and nickel production in the final quarter of 2014. Mwana said its gold production at the Freda Rebecca project in Zimbabwe dropped 14% in the three months to the end of December, its financial third quarter, to 14,298 ounces from 16,555 ounces in the second quarter.

By Daniel Ruiz; danielruiz@alliancenews.com

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
16 May 2024 20:09

TRADING UPDATES: Bens Creek considers administration; Nexxen inks deal

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
16 May 2024 11:46

Angle reports promising results from Parsortix study

(Sharecast News) - Angle, the AIM-listed liquid biopsy company which specialises in circulating tumour cell (CTC) solutions, has announced the results of a clinical study which show that its Parsortix system could be used to predict progression-free survival in patients with ovarian cancer.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 10:52

AIM WINNERS & LOSERS: Fletcher King optimistic; Angle in Astra deal

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more
3 May 2024 08:48

LONDON MARKET OPEN: Confident start before US jobs data

(Alliance News) - Stock prices in London opened higher on Friday, on the rising conviction that the afternoon's US jobs report will be softer, cooling some hawkish Federal Reserve interest rate expectations.

Read more
3 May 2024 07:58

Angle strikes supplier deal with AstraZeneca

(Sharecast News) - Liquid biopsy technology firm Angle has struck a supplier deal with pharmaceutical giant AstraZeneca to develop an androgen receptor detection assay to enhance prostate cancer studies.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
24 Apr 2024 17:06

CORRECT: No record close for FTSE 100; mixed trade in US

(Correcting day of the week in the opening sentence.)

Read more
24 Apr 2024 17:00

LONDON MARKET CLOSE: No record close for FTSE 100; mixed trade in US

(Alliance News) - Stock prices in London closed lower on Thursday, with the FTSE 100's recent rally taking a pause for breath, but not after hitting another record high.

Read more
24 Apr 2024 10:32

Angle shares jump on supplier agreement with with AstraZeneca

(Alliance News) - Angle PLC shares rose on Wednesday, after it signed a contract with AstraZeneca PLC.

Read more
24 Apr 2024 10:10

AIM WINNERS & LOSERS: Filtronic jumps as lifts outlook

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
22 Apr 2024 16:52

IN BRIEF: Angle granted patents in US and Europe for Cellkeep slide

Angle PLC - Surrey-based medical diagnostics provider - Says it has been granted a European and US patent for its CellKeep slide. "We are delighted to have secured intellectual property rights for our proprietary CellKeep slide in two major jurisdictions....This is a significant technology advancement for the [circulating tumor cell] liquid biopsy field and another step towards enabling biomarker-guided precision medicine for people with cancer," says Chief Executive Officer Andrew Newland. The CellKeep slide was developed by Angle to reduce cell loss during the transfer of CTCs to the microscope slide and to protect the morphology of the harvested cells.

Read more
22 Apr 2024 06:59

Angle granted European patent for CellKeep, US patent imminent

(Sharecast News) - Liquid biopsy specialist Angle announced on Monday that it has received a European patent for its 'CellKeep' slide, as it anticipated the imminent grant of an equivalent US patent application.

Read more
22 Jan 2024 18:03

IN BRIEF: Angle highlights supportive data for DNA analysis tool

Angle PLC - Surrey-based medical diagnostics provider - Announces publication of a peer-reviewed paper in a special issue of the journal - "Current Issues in Molecular Biology" Special Issue: Advanced Solutions for Cancer Therapy. Article brings together supporting evidence for the additional and complementary information that can be obtained from circulating tumour cells, demonstrating the value of a dual analyte approach for both CTCs and ctDNA (fragments of DNA released mainly by dying cells). Angle recently announced breakthrough data for real-time parallel next generation sequencing DNA analysis of both ctDNA and CTCs from a single tube of patient blood, using a pan-cancer panel run on an Illumina NGS system.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.